ipamorelin and cjc-1295 nasal spray w/o DAC 5mg + 5mg Kit cjc 1295 ipamorelin peptide injections

Key Benefits of Ipamorelin/CJC-1295 (no DAC) 5MG/5MG Combines two peptides with complementary research roles Supports studies of growth hormone release and regulation Provides specificity without altering cortisol or prolactin Supplied as a stable lyophilized powder for consistency Shorter half-life of CJC-1295 (no DAC) allows precise testing Offers 99% purity for reliable laboratory results Designed strictly for research under controlled conditions Research Use Only Legal Disclaimer All products on this site are for research and development use only

By supporting metabolic efficiency and energy utilization, the stack contributes to an environment where lean muscle development is prioritized while excess fat storage is minimized

Not as a pair

In vitro and animal models have used ipamorelin to evaluate how selective GHSR activation influences second-messenger dynamics and pathway coupling across Gq- and Gs-associated signaling nodes

According to the FDAs 2023 guidance, Ipamorelin is currently not eligible for compounding under Section 503A and is classified as a Category B bulk drug substance due to a lack of safety data